(±)Equol inhibits invasion in prostate cancer DU145 cells possibly via down-regulation of matrix metalloproteinase-9, matrix metalloproteinase-2 and urokinase-type plasminogen activator by antioxidant activity

Journal of Clinical Biochemistry and Nutrition

Volumn 51, Issue 1, 2012, Pages 61-67

  Zheng, Wei ^a   Zhang, Yumei ^a   Ma, Defu ^a   Shi, Yuhui ^a   Liu, Changqiu ^a   Wang, Peiyu ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

( )equol; DU145 cell; Invasion antioxidant; Prostate cancer

Indexed keywords

DAIDZEIN; EQUOL; GELATINASE A; GELATINASE B; GENISTEIN; MALONALDEHYDE; MESSENGER RNA; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SUPEROXIDE DISMUTASE; TENSIN; TRANSCRIPTION FACTOR NRF2; UROKINASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL VIABILITY; CHROMOSOME 10; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIPID PEROXIDATION; PROSTATE CANCER; PROTEIN EXPRESSION;

EID: 84863477801     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.11-54     Document Type: Article

References (31)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Bubendorf L, Schöpfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000; 31: 578-583. (Pubitemid 30323983)
3. Löf M, Weiderpass E. Epidemiologic evidence suggests that dietary phytoestrogen intake is associated with reduced risk of breast, endometrial, and prostate cancers. Nutrition Research 2006; 26: 609-619. (Pubitemid 44895476)
4. Sonoda T, Nagata Y, Mori M, et al. A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet. Cancer Sci 2004; 95: 238-242. (Pubitemid 38489090)
5. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975; 15: 617-631.
6. Ozasa K, Nakao M, Watanabe Y, et al. Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci 2004; 95: 65-71. (Pubitemid 38208409)
7. Rabiau N, Kossaï M, Braud M, et al. Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by polymerase chain reaction arrays in human prostate cancer cell lines. Cancer Epidemiol 2010; 34: 200-206.
8. Choi EJ, Kim GH. Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells. Phytomedicine 2008; 15: 683-690.
9. Li Y, Kucuk O, Hussain M, Abrams J, Cher ML, Sarkar FH. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. Cancer Res 2006; 66: 4816-4825.
10. Haberland J, Bertz J, Wolf U, Ziese T, Kurth BM. German cancer statistics 2004. BMC Cancer 2010; 10: 52.
11. El Touny LH, Banerjee PP. Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res 2009; 69: 3695-3703.
12. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 2000; 36: 27-32. (Pubitemid 30317832)
13. Morton MS, Arisaka O, Miyake N, Morgan LD, Evans BA. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr 2002; 132: 3168-3171.
14. Liu B, Qin L, Liu A, et al. Prevalence of the equol-producer phenotype and its relationship with dietary isoflavone and serum lipids in healthy Chinese adults. J Epidemiol 2010; 20: 377-384.
15. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 2002; 132: 3577-3584. (Pubitemid 35435031)
16. Magee PJ, Raschke M, Steiner C, et al. Equol: a comparison of the effects of the racemic compound with that of the purified S-enantiomer on the growth, invasion, and DNA integrity of breast and prostate cells in vitro. Nutr Cancer 2006; 54: 232-242. (Pubitemid 44316306)
17. Choi EJ, Ahn WS, Bae SM. Equol induces apoptosis through cytochrome c-mediated caspases cascade in human breast cancer MDA-MB-453 cells. Chem Biol Interact 2009; 177: 7-11.
18. Liu CQ, Zhang YM, Zheng W, et al. The Effects of equol and bioactive components of soybean on growth of human prostatic cancer cells Dul45 in vitro (in Chinese). Food and Nutrition in China 2010; 6: 70-72.
19. Morton MS, Chan PS, Cheng C, et al. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate 1997; 32: 122-128. (Pubitemid 27280356)
20. Hedlund TE, Maroni PD, Ferucci PG, et al. Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in caucasian men. J Nutr 2005; 135: 1400-1406. (Pubitemid 40799602)
21. Magee PJ, McGlynn H, Rowland IR. Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro. Cancer Lett 2004; 208: 35-41. (Pubitemid 38501781)
22. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer 1997; 80 (Suppl): 1529-1537. (Pubitemid 27444024)
23. Itoh Y, Nagase H. Matrix metalloproteinases in cancer. Essays Biochem 2002; 38: 21-36. (Pubitemid 36589192)
24. Duffy MJ, Duggan C. The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer. Clin Biochem 2004; 37: 541-548. (Pubitemid 38845017)
25. Xu L, Ding Y, Catalona WJ, et al. MEK4 function, genistein treatment, and invasion of human prostate cancer cells. J Natl Cancer Inst 2009; 101: 1141-1155.
26. Kim SC, Magesh V, Jeong SJ, et al. Ethanol extract of Ocimum sanctum exerts anti-metastatic activity through inactivation of matrix metalloproteinase-9 and enhancement of anti-oxidant enzymes. Food Chem Toxicol 2010; 48: 1478-1482.
27. Kunigal S, Lakka SS, Gondi CS, Estes N, Rao JS. RNAi-mediated down-regulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int J Cancer 2007; 121: 2307-2316. (Pubitemid 47585614)
28. Mitchell JH, Gardner PT, McPhail DB, Morrice PC, Collins AR, Duthie GG. Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys 1998; 360: 142-148. (Pubitemid 29010923)
29. Warabi E, Takabe W, Minami T, et al. Shear stress stabilizes NF-E2-related factor 2 and induces antioxidant genes in endothelial cells: role of reactive oxygen/nitrogen species. Free Radic Biol Med 2007; 42: 260-269. (Pubitemid 44959746)
30. Huo YY, Li G, Duan RF, et al. PTEN deletion leads to deregulation of antioxidants and increased oxidative damage in mouse embryonic fibroblasts. Free Radic Biol Med 2008; 44: 1578-1591.
31. Li MH, Cha YN, Surh YJ. Peroxynitrite induces HO-1 expression via PI3K/Akt-dependent activation of NF-E2-related factor 2 in PC12 cells. Free Radic Biol Med 2006; 41: 1079-1091.